1
|
Cho K, Lee J, Kim J. Integrated high-throughput drug screening microfluidic system for comprehensive ocular toxicity assessment. Toxicol In Vitro 2024; 98:105843. [PMID: 38735502 DOI: 10.1016/j.tiv.2024.105843] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2024] [Revised: 04/29/2024] [Accepted: 05/08/2024] [Indexed: 05/14/2024]
Abstract
Traditional experimental methodologies suffer from a few limitations in the toxicological evaluation of the preservatives added to eye drops. In this study, we overcame these limitations by using a microfluidic device. We developed a microfluidic system featuring a gradient concentration generator for preservative dosage control with microvalves and micropumps, automatically regulated by a programmable Arduino board. This system facilitated the simultaneous toxicological evaluation of human corneal epithelial cells against eight different concentrations of preservatives, allowing for quadruplicate experiments in a single run. In our study, the IC50 values for healthy eyes and those affected with dry eyes syndrome showed an approximately twofold difference. This variation is likely attributable to the duration for which the preservative remained in contact with corneal cells before being washed off by the medium, suggesting the significance of exposure time in the cytotoxic effect of preservatives. Our microfluidic system, automated by Arduino, simulated healthy and dry eye environments to study benzalkonium chloride toxicity and revealed significant differences in cell viability, with IC50 values of 0.0033% for healthy eyes and 0.0017% for dry eyes. In summary, we implemented the pinch-to-zoom feature of an electronic tablet in our microfluidic system, offering innovative alternatives for eye research.
Collapse
Affiliation(s)
- Kyongjin Cho
- Dept. of Ophthalmology, College of Medicine, Dankook University, Cheonan 31116, Republic of Korea
| | - Jinho Lee
- Research Institute of Natural Science and Department of Physics Education, Gyeongsang National University, Jinju, 52828, Republic of Korea
| | - Jeongyun Kim
- Dept. of Physics, College of Natural Science, Dankook University, Cheonan 31116, Republic of Korea.
| |
Collapse
|
2
|
Machado AV, Menezes LRO, Santana AAM, Marques MN, de Lima AK, Cano A, Severino P, Souto EB, Cardoso JC. Genipa americana L.: A New Phytochemical for White Hair Coloring. Chem Biodivers 2023; 20:e202300083. [PMID: 37681514 DOI: 10.1002/cbdv.202300083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2023] [Accepted: 08/18/2023] [Indexed: 09/09/2023]
Abstract
This work describes a new hair dyeing methodology using a chemical reaction between geniposide, an iridoid glycoside extracted from the fruit of Genipa americana (geniposide extract, GE) and the amine group of hair keratin. The influence of reaction conditions (pH, temperature, and extract concentration) on the staining of hair fibers, color development, fiber morphology, and mechanical hair properties of black and white human hair samples, was evaluated before and after GE dyeing treatment. Eye contact safety of GE was also studied using HET-CAM. The treatment of white hair fibers using GE at 20 mg mL-1 , temperature of 80 °C and pH 5.5 presented the greatest color change (ΔE=54.0). The higher pH influence was observed at pH 10.0 on white hair tresses (ΔE=6.8), using an GE concentration of 20 mg mL-1 and room temperature (25 °C). Treated samples showed marked changes on mechanical and morphological properties. The HET-CAM did not show any change, thus demonstrating that using GE is safe. In conclusion, the temperature and concentration of the extract were the variables that mostly influenced the color and hair damage. A new approach for hair dyeing was established where iridoids may potentially be useful as a natural hair dyeing.
Collapse
Affiliation(s)
- Andréa V Machado
- University of Tiradentes (Unit), Av Murilo Dantas, 300, 49010-390, Aracaju, Brazil
| | - Luana R O Menezes
- University of Tiradentes (Unit), Av Murilo Dantas, 300, 49010-390, Aracaju, Brazil
| | - Adilson A M Santana
- University of Tiradentes (Unit), Av Murilo Dantas, 300, 49010-390, Aracaju, Brazil
| | - Maria N Marques
- University of Tiradentes (Unit), Av Murilo Dantas, 300, 49010-390, Aracaju, Brazil
- Institute of Technology and Research (ITP), Av Murilo Dantas, 300, 49010-390, Aracaju, Brazil
| | - Adriana K de Lima
- University of Tiradentes (Unit), Av Murilo Dantas, 300, 49010-390, Aracaju, Brazil
| | - Amanda Cano
- Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, Av. Diagonal 645, 08028, Barcelona, Spain
- Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), 28031, Madrid, Spain
| | - Patrícia Severino
- University of Tiradentes (Unit), Av Murilo Dantas, 300, 49010-390, Aracaju, Brazil
- Institute of Technology and Research (ITP), Av Murilo Dantas, 300, 49010-390, Aracaju, Brazil
| | - Eliana B Souto
- Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313, Porto, Portugal
- UCIBIO - Applied Molecular Biosciences Unit, MEDTECH, Faculty of Pharmacy, University of Porto, 4050-313, Porto, Portugal
- Associate Laboratory i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313, Porto, Portugal
| | - Juliana C Cardoso
- University of Tiradentes (Unit), Av Murilo Dantas, 300, 49010-390, Aracaju, Brazil
- Institute of Technology and Research (ITP), Av Murilo Dantas, 300, 49010-390, Aracaju, Brazil
| |
Collapse
|
3
|
Gomes JAP, Azar DT, Baudouin C, Bitton E, Chen W, Hafezi F, Hamrah P, Hogg RE, Horwath-Winter J, Kontadakis GA, Mehta JS, Messmer EM, Perez VL, Zadok D, Willcox MDP. TFOS Lifestyle: Impact of elective medications and procedures on the ocular surface. Ocul Surf 2023; 29:331-385. [PMID: 37087043 DOI: 10.1016/j.jtos.2023.04.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2023] [Accepted: 04/10/2023] [Indexed: 04/24/2023]
Abstract
The word "elective" refers to medications and procedures undertaken by choice or with a lower grade of prioritization. Patients usually use elective medications or undergo elective procedures to treat pathologic conditions or for cosmetic enhancement, impacting their lifestyle positively and, thus, improving their quality of life. However, those interventions can affect the homeostasis of the tear film and ocular surface. Consequently, they generate signs and symptoms that could impair the patient's quality of life. This report describes the impact of elective topical and systemic medications and procedures on the ocular surface and the underlying mechanisms. Moreover, elective procedures performed for ocular diseases, cosmetic enhancement, and non-ophthalmic interventions, such as radiotherapy and bariatric surgery, are discussed. The report also evaluates significant anatomical and biological consequences of non-urgent interventions to the ocular surface, such as neuropathic and neurotrophic keratopathies. Besides that, it provides an overview of the prophylaxis and management of pathological conditions resulting from the studied interventions and suggests areas for future research. The report also contains a systematic review investigating the quality of life among people who have undergone small incision lenticule extraction (SMILE). Overall, SMILE refractive surgery seems to cause more vision disturbances than LASIK in the first month post-surgery, but less dry eye symptoms in long-term follow up.
Collapse
Affiliation(s)
- José Alvaro P Gomes
- Dept. of Ophthalmology and Visual Sciences, Federal University of Sao Paulo/Paulista School of Medicine (UNIFESP/EPM), Sao Paulo, SP, Brazil.
| | - Dimitri T Azar
- University of Illinois College of Medicine, Chicago, IL, USA
| | - Christophe Baudouin
- Quinze-Vingts National Eye Hospital & Vision Institute, IHU FOReSIGHT, Paris, France
| | - Etty Bitton
- Ecole d'optométrie, Université de Montréal, Montréal, Canada
| | - Wei Chen
- Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
| | | | - Pedram Hamrah
- Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA
| | - Ruth E Hogg
- Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Belfast, UK
| | | | | | | | | | - Victor L Perez
- Foster Center for Ocular Immunology, Duke University Eye Center, Durham, NC, USA
| | - David Zadok
- Shaare Zedek Medical Center, Affiliated to the Hebrew University, School of Medicine, Jerusalem, Israel
| | - Mark D P Willcox
- School of Optometry and Vision Science, University of New South Wales, Sydney, Australia
| |
Collapse
|
4
|
Ghazwani M, Hani U, Alqarni MH, Alam A. Development and Characterization of Methyl-Anthranilate-Loaded Silver Nanoparticles: A Phytocosmetic Sunscreen Gel for UV Protection. Pharmaceutics 2023; 15:pharmaceutics15051434. [PMID: 37242676 DOI: 10.3390/pharmaceutics15051434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2023] [Revised: 04/25/2023] [Accepted: 05/02/2023] [Indexed: 05/28/2023] Open
Abstract
Methyl anthranilate (MA) is a naturally derived compound commonly used in cosmetic products, such as skin care products, fine perfumes, etc. The goal of this research was to develop a UV-protective sunscreen gel using methyl-anthranilate-loaded silver nanoparticles (MA-AgNPs). The microwave approach was used to develop the MA-AgNPs, which were then optimized using Box-Behnken Design (BBD). Particle size (Y1) and absorbance (Y2) were chosen as the response variables, while AgNO3 (X1), methyl anthranilate concentration (X2), and microwave power (X3) were chosen as the independent variables. Additionally, the prepared AgNPs were approximated for investigations on in vitro active ingredient release, dermatokinetics, and confocal laser scanning microscopy (CLSM). The study's findings showed that the optimal MA-loaded AgNPs formulation had a particle size, polydispersity index, zeta potential, and percentage entrapment efficiency (EE) of 200 nm, 0.296 mV, -25.34 mV, and 87.88%, respectively. The image from transmission electron microscopy (TEM) demonstrated the spherical shape of the nanoparticles. According to an in vitro investigation on active ingredient release, MA-AgNPs and MA suspension released the active ingredient at rates of 81.83% and 41.62%, respectively. The developed MA-AgNPs formulation was converted into a gel by using Carbopol 934 as a gelling agent. The spreadability and extrudability of MA-AgNPs gel were found to be 16.20 and 15.190, respectively, demonstrating that the gel may spread very easily across the skin's surface. The MA-AgNPs formulation demonstrated improved antioxidant activity in comparison to pure MA. The MA-AgNPs sunscreen gel formulation displayed non-Newtonian pseudoplastic behaviour, which is typical of skin-care products, and was found to be stable during the stability studies. The sun protection factor (SPF) value of MA-AgNPG was found to be 35.75. In contrast to the hydroalcoholic Rhodamine B solution (5.0 µm), the CLSM of rat skin treated with the Rhodamine B-loaded AgNPs formulation showed a deeper penetration of 35.0 µm, indicating the AgNPs formulation was able to pass the barrier and reach the skin's deeper layers for more efficient delivery of the active ingredient. This can help with skin conditions where deeper penetration is necessary for efficacy. Overall, the results indicated that the BBD-optimized MA-AgNPs provided some of the most important benefits over conventional MA formulations for the topical delivery of methyl anthranilate.
Collapse
Affiliation(s)
- Mohammed Ghazwani
- Department of Pharmaceutics, College of Pharmacy, King Khalid University, P.O. Box 1882, Abha 61441, Saudi Arabia
| | - Umme Hani
- Department of Pharmaceutics, College of Pharmacy, King Khalid University, P.O. Box 1882, Abha 61441, Saudi Arabia
| | - Mohammed H Alqarni
- Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj 11942, Saudi Arabia
| | - Aftab Alam
- Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj 11942, Saudi Arabia
| |
Collapse
|
5
|
Abrantes DC, Rogerio CB, Campos EVR, Germano-Costa T, Vigato AA, Machado IP, Sepulveda AF, Lima R, de Araujo DR, Fraceto LF. Repellent active ingredients encapsulated in polymeric nanoparticles: potential alternative formulations to control arboviruses. J Nanobiotechnology 2022; 20:520. [PMID: 36496396 PMCID: PMC9741802 DOI: 10.1186/s12951-022-01729-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2022] [Accepted: 11/28/2022] [Indexed: 12/13/2022] Open
Abstract
Dengue, yellow fever, Chinkungunya, Zika virus, and West Nile fever have infected millions and killed a considerable number of humans since their emergence. These arboviruses are transmitted by mosquito bites and topical chemical repellents are the most commonly used method to protect against vector arthropod species. This study aimed to develop a new generation of repellent formulations to promote improved arboviruses transmission control. A repellent system based on polycaprolactone (PCL)-polymeric nanoparticles was developed for the dual encapsulation of IR3535 and geraniol and further incorporation into a thermosensitive hydrogel. The physicochemical and morphological parameters of the prepared formulations were evaluated by dynamic light scattering (DLS), nano tracking analysis (NTA), atomic force microscopy (AFM). In vitro release mechanisms and permeation performance were evaluated before and after nanoparticles incorporation into the hydrogels. FTIR analysis was performed to evaluate the effect of formulation epidermal contact. Potential cytotoxicity was evaluated using the MTT reduction test and disc diffusion methods. The nanoparticle formulations were stable over 120 days with encapsulation efficiency (EE) of 60% and 99% for IR3535 and geraniol, respectively. AFM analysis revealed a spherical nanoparticle morphology. After 24 h, 7 ± 0.1% and 83 ± 2% of the GRL and IR3535, respectively, were released while the same formulation incorporated in poloxamer 407 hydrogel released 11 ± 0.9% and 29 ± 3% of the loaded GRL and IR3535, respectively. GRL permeation from PCL nanoparticles and PCL nanoparticles in the hydrogel showed similar profiles, while IR3535 permeation was modulated by formulation compositions. Differences in IR3535 permeated amounts were higher for PCL nanoparticles in the hydrogels (36.9 ± 1.1 mg/cm2) compared to the IR3535-PCL nanoparticles (29.2 ± 1.5 mg/cm2). However, both active permeation concentrations were low at 24 h, indicating that the formulations (PCL nanoparticles and PCL in hydrogel) controlled the bioactive percutaneous absorption. Minor changes in the stratum corneum (SC) caused by interaction with the formulations may not represent a consumer safety risk. The cytotoxicity results presented herein indicate the carrier systems based on poly-epsilon caprolactone (PCL) exhibited a reduced toxic effect when compared to emulsions, opening perspectives for these systems to be used as a tool to prolong protection times with lower active repellent concentrations.
Collapse
Affiliation(s)
- Daniele Carvalho Abrantes
- grid.410543.70000 0001 2188 478XSão Paulo State University (UNESP), Institute of Science and Technology, Avenida Três de Março 511, Alto da Boa Vista, Sorocaba, São Paulo 18087-180 Brazil
| | - Carolina Barbara Rogerio
- grid.410543.70000 0001 2188 478XSão Paulo State University (UNESP), Institute of Science and Technology, Avenida Três de Março 511, Alto da Boa Vista, Sorocaba, São Paulo 18087-180 Brazil
| | - Estefânia Vangelie Ramos Campos
- grid.410543.70000 0001 2188 478XSão Paulo State University (UNESP), Institute of Science and Technology, Avenida Três de Março 511, Alto da Boa Vista, Sorocaba, São Paulo 18087-180 Brazil
| | - Tais Germano-Costa
- grid.442238.b0000 0001 1882 0259Laboratory of Bioactivity Assessment and Toxicology of Nanomaterials, University of Sorocaba, Sorocaba, São Paulo Brazil
| | - Aryane Alves Vigato
- grid.412368.a0000 0004 0643 8839Human and Natural Sciences Center, Federal University of ABC, Santo André, São Paulo 09210-580 Brazil
| | - Ian Pompermeyer Machado
- grid.412368.a0000 0004 0643 8839Human and Natural Sciences Center, Federal University of ABC, Santo André, São Paulo 09210-580 Brazil
| | - Anderson Ferreira Sepulveda
- grid.412368.a0000 0004 0643 8839Human and Natural Sciences Center, Federal University of ABC, Santo André, São Paulo 09210-580 Brazil
| | - Renata Lima
- grid.442238.b0000 0001 1882 0259Laboratory of Bioactivity Assessment and Toxicology of Nanomaterials, University of Sorocaba, Sorocaba, São Paulo Brazil
| | - Daniele Ribeiro de Araujo
- grid.412368.a0000 0004 0643 8839Human and Natural Sciences Center, Federal University of ABC, Santo André, São Paulo 09210-580 Brazil
| | - Leonardo Fernandes Fraceto
- grid.410543.70000 0001 2188 478XSão Paulo State University (UNESP), Institute of Science and Technology, Avenida Três de Março 511, Alto da Boa Vista, Sorocaba, São Paulo 18087-180 Brazil
| |
Collapse
|
6
|
Gupta V, Mohapatra S, Mishra H, Farooq U, Kumar K, Ansari MJ, Aldawsari MF, Alalaiwe AS, Mirza MA, Iqbal Z. Nanotechnology in Cosmetics and Cosmeceuticals—A Review of Latest Advancements. Gels 2022; 8:gels8030173. [PMID: 35323286 PMCID: PMC8951203 DOI: 10.3390/gels8030173] [Citation(s) in RCA: 33] [Impact Index Per Article: 16.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2022] [Revised: 02/24/2022] [Accepted: 03/07/2022] [Indexed: 11/16/2022] Open
Abstract
Nanotechnology has the potential to generate advancements and innovations in formulations and delivery systems. This fast-developing technology has been widely exploited for diagnostic and therapeutic purposes. Today, cosmetic formulations incorporating nanotechnology are a relatively new yet very promising and highly researched area. The application of nanotechnology in cosmetics has been shown to overcome the drawbacks associated with traditional cosmetics and also to add more useful features to a formulation. Nanocosmetics and nanocosmeceuticals have been extensively explored for skin, hair, nails, lips, and teeth, and the inclusion of nanomaterials has been found to improve product efficacy and consumer satisfaction. This is leading to the replacement of many traditional cosmeceuticals with nanocosmeceuticals. However, nanotoxicological studies on nanocosmeceuticals have raised concerns in terms of health hazards due to their potential skin penetration, resulting in toxic effects. This review summarizes various nanotechnology-based approaches being utilized in the delivery of cosmetics as well as cosmeceutical products, along with relevant patents. It outlines their benefits, as well as potential health and environmental risks. Further, it highlights the regulatory status of cosmeceuticals and analyzes the different regulatory guidelines in India, Europe, and the USA and discusses the different guidelines and recommendations issued by various regulatory authorities. Finally, this article seeks to provide an overview of nanocosmetics and nanocosmeceuticals and their applications in cosmetic industries, which may help consumers and regulators to gain awareness about the benefits as well as the toxicity related to the continuous and long-term uses of these products, thus encouraging their judicious use.
Collapse
Affiliation(s)
- Vaibhav Gupta
- Nanotechnology Lab, School of Pharmaceutics Education and Research (SPER), Jamia Hamdard University, New Delhi 110062, Delhi, India; (V.G.); (S.M.); (U.F.); (K.K.)
| | - Sradhanjali Mohapatra
- Nanotechnology Lab, School of Pharmaceutics Education and Research (SPER), Jamia Hamdard University, New Delhi 110062, Delhi, India; (V.G.); (S.M.); (U.F.); (K.K.)
| | - Harshita Mishra
- Smart Society Research Team, Faculty of Business and Economics, Mendel University, 61300 Brno, Czech Republic;
| | - Uzma Farooq
- Nanotechnology Lab, School of Pharmaceutics Education and Research (SPER), Jamia Hamdard University, New Delhi 110062, Delhi, India; (V.G.); (S.M.); (U.F.); (K.K.)
| | - Keshav Kumar
- Nanotechnology Lab, School of Pharmaceutics Education and Research (SPER), Jamia Hamdard University, New Delhi 110062, Delhi, India; (V.G.); (S.M.); (U.F.); (K.K.)
| | - Mohammad Javed Ansari
- Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj 16278, Saudi Arabia or (M.J.A.); (M.F.A.); (A.S.A.)
| | - Mohammed F. Aldawsari
- Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj 16278, Saudi Arabia or (M.J.A.); (M.F.A.); (A.S.A.)
| | - Ahmed S. Alalaiwe
- Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj 16278, Saudi Arabia or (M.J.A.); (M.F.A.); (A.S.A.)
| | - Mohd Aamir Mirza
- Nanotechnology Lab, School of Pharmaceutics Education and Research (SPER), Jamia Hamdard University, New Delhi 110062, Delhi, India; (V.G.); (S.M.); (U.F.); (K.K.)
- Correspondence: (M.A.M.); (Z.I.); Tel.: +98-11733016 (Z.I.)
| | - Zeenat Iqbal
- Nanotechnology Lab, School of Pharmaceutics Education and Research (SPER), Jamia Hamdard University, New Delhi 110062, Delhi, India; (V.G.); (S.M.); (U.F.); (K.K.)
- Correspondence: (M.A.M.); (Z.I.); Tel.: +98-11733016 (Z.I.)
| |
Collapse
|
7
|
da Silva JF, Corrêa DS, Campos ÉL, Leite GZ, de Oliveira JDM, Fachini J, da Silva J, Obach ES, Campo LF, Grivicich I, de Amorim HLN, Picada JN. Evaluation of toxicological aspects of three new benzoxazole compounds with sunscreen photophysical properties using in silico and in vitro methods. Toxicol In Vitro 2021; 79:105300. [PMID: 34933087 DOI: 10.1016/j.tiv.2021.105300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2021] [Revised: 11/23/2021] [Accepted: 12/11/2021] [Indexed: 11/18/2022]
Abstract
Sunscreening chemicals protect against damage caused by sunlight most absorbing UVA or UVB radiations. In this sense, 2-(2'-hydroxyphenyl)benzoxazole derivatives with amino substituents in the 4' and 5' positions have an outstandingly high Sun Protection Factor and adequate photostability, but their toxicity is not yet known. This study aimed to evaluate the toxicity of three synthetic 2-(2'-hydroxyphenyl)benzoxazole derivatives for their possible application as sunscreens. In silico tools were used in order to assess potential risks regarding mutagenic, carcinogenic, and skin sensitizing potential. Bioassays were performed in L929 cells to assess cytotoxicity in MTT assay and genotoxic activities in the Comet assay and micronucleus test. Also, the Salmonella/microsome assay was performed to evaluate gene mutations. The in silico predictions indicate a low risk of mutagenicity and carcinogenicity of the compounds while the skin sensitizing potential was low or inconclusive. The 2-(4'-amino-2'-hydroxyphenyl)benzoxazol compound was the most cytotoxic and genotoxic among the compounds evaluated in L929 cells, but none induced mutations in the Salmonella/microsome assay. The amino substituted at the 4' position of the phenyl ring appears to have greater toxicological risks than substituents at the 5' position of 2-(phenyl)benzoxazole. The findings warrant further studies of these compounds in cosmetic formulations.
Collapse
Affiliation(s)
- Jâmeson Ferreira da Silva
- Laboratório de Genética Toxicológica, Universidade Luterana do Brasil (ULBRA), Av. Farroupilha, 8001, CEP: 92425-900 Canoas, RS, Brazil; Centro de Pesquisa em Produto e Desenvolvimento (CEPPED), Universidade Luterana do Brasil (ULBRA), Av. Farroupilha, 8001, CEP: 92425-900 Canoas, RS, Brazil
| | - Dione Silva Corrêa
- Centro de Pesquisa em Produto e Desenvolvimento (CEPPED), Universidade Luterana do Brasil (ULBRA), Av. Farroupilha, 8001, CEP: 92425-900 Canoas, RS, Brazil
| | - Érico Leite Campos
- Laboratório de Genética Toxicológica, Universidade Luterana do Brasil (ULBRA), Av. Farroupilha, 8001, CEP: 92425-900 Canoas, RS, Brazil; Centro de Pesquisa em Produto e Desenvolvimento (CEPPED), Universidade Luterana do Brasil (ULBRA), Av. Farroupilha, 8001, CEP: 92425-900 Canoas, RS, Brazil
| | - Giovana Zamprônio Leite
- Laboratório de Genética Toxicológica, Universidade Luterana do Brasil (ULBRA), Av. Farroupilha, 8001, CEP: 92425-900 Canoas, RS, Brazil; Centro de Pesquisa em Produto e Desenvolvimento (CEPPED), Universidade Luterana do Brasil (ULBRA), Av. Farroupilha, 8001, CEP: 92425-900 Canoas, RS, Brazil
| | - João Denis Medeiros de Oliveira
- Laboratório de Genética Toxicológica, Universidade Luterana do Brasil (ULBRA), Av. Farroupilha, 8001, CEP: 92425-900 Canoas, RS, Brazil
| | - Jean Fachini
- Laboratório de Genética Toxicológica, Universidade Luterana do Brasil (ULBRA), Av. Farroupilha, 8001, CEP: 92425-900 Canoas, RS, Brazil
| | - Juliana da Silva
- Laboratório de Genética Toxicológica, Universidade Luterana do Brasil (ULBRA), Av. Farroupilha, 8001, CEP: 92425-900 Canoas, RS, Brazil; Laboratório de Genetica Toxicológica, Universidade La Salle, Av. Victor Barreto, 2288, CEP: 92010-000 Canoas, RS, Brazil
| | - Eliane Sempé Obach
- Laboratório de Tecnologia Farmacêutica, Universidade Luterana do Brasil (ULBRA), Av. Farroupilha, 8001, CEP: 92425-900 Canoas, RS, Brazil
| | - Leandra Franciscato Campo
- Laboratório de Novos Materiais Orgânicos e Quimica Forense, Universidade Federal do Rio Grande do Sul, Av. Bento Gonçalves, 9500, CEP: 90650-001 Porto Alegre, RS, Brazil
| | - Ivana Grivicich
- Laboratório de Biologia do Câncer, Universidade Luterana do Brasil (ULBRA), Farroupilha Avenue 8001, CEP: 92425-900 Canoas, RS, Brazil
| | | | - Jaqueline Nascimento Picada
- Laboratório de Genética Toxicológica, Universidade Luterana do Brasil (ULBRA), Av. Farroupilha, 8001, CEP: 92425-900 Canoas, RS, Brazil; Laboratório de Novos Materiais Orgânicos e Quimica Forense, Universidade Federal do Rio Grande do Sul, Av. Bento Gonçalves, 9500, CEP: 90650-001 Porto Alegre, RS, Brazil.
| |
Collapse
|
8
|
Abu Hajleh MN, Abu-Huwaij R, Al-Samydai A, Al-Halaseh LK, Al-Dujaili EA. The revolution of cosmeceuticals delivery by using nanotechnology: A narrative review of advantages and side effects. J Cosmet Dermatol 2021; 20:3818-3828. [PMID: 34510691 DOI: 10.1111/jocd.14441] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2021] [Accepted: 08/27/2021] [Indexed: 11/28/2022]
Abstract
BACKGROUND The qualified and paradigm jump in the formulation and production of cosmeceuticals refer in some way to the great revolution in nanotechnology. Nowadays, the industry of nano-formulated cosmeceuticals plays a significant and essential role in the evolution and growth of the pharmaceutical industries. This review manuscript focuses on the use of nanocarriers in delivering the cosmetic agents into the target area such as skin, hair, and nails. METHODS Many steps were performed in the preparation of this review including identification of different classes of nanocarriers for delivery of nanocosmeceuticals, literature survey of relevantstudies regarding the applications of nanotechnology in cosmeceuticals and their toxicological effects. RESULTS When nanoparticles introduced in the cosmetic industry, the quality and the elegance of the final products were raised significantly. Sadly, this revolution is accompanied by many health hazards as these tiny molecules can penetrate intact skin barriers and cause undesired effects. Cosmeceuticals with nanotechnology include sunscreens, hair cleansing products, nail products, and agents fighting fine lines. CONCLUSIONS The expansion and growth of the cosmetic industry and the introduction of nanotechnology in cosmeceuticals industry necessitates the urgent need for scientific research investigating their efficacy, safety profile and use.
Collapse
Affiliation(s)
- Maha N Abu Hajleh
- Department of Cosmetic Science, Pharmacological and Diagnostic Research Centre, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, Amman, Jordan
| | - Rana Abu-Huwaij
- Pharmacological and Diagnostic Research Centre, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan
| | - Ali Al-Samydai
- Pharmacological and Diagnostic Research Centre, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan
| | - Lidia Kamal Al-Halaseh
- Department of Pharmaceutical Chemistry, Faculty of pharmacy, Mutah University, Al-Karak, Jordan
| | - Emad A Al-Dujaili
- Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Scotland, UK
| |
Collapse
|
9
|
Petit RG, Cano A, Ortiz A, Espina M, Prat J, Muñoz M, Severino P, Souto EB, García ML, Pujol M, Sánchez-López E. Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics. Int J Mol Sci 2021; 22:4983. [PMID: 34067151 PMCID: PMC8125586 DOI: 10.3390/ijms22094983] [Citation(s) in RCA: 27] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2021] [Revised: 04/30/2021] [Accepted: 05/06/2021] [Indexed: 12/12/2022] Open
Abstract
Research in the pathogenesis of inflammatory skin diseases, such as skin dermatitis and psoriasis, has experienced some relevant breakthroughs in recent years. The understanding of age-related factors, gender, and genetic predisposition of these multifactorial diseases has been instrumental for the development of new pharmacological and technological treatment approaches. In this review, we discuss the molecular mechanisms behind the pathological features of psoriasis, also addressing the currently available treatments and novel therapies that are under clinical trials. Innovative therapies developed over the last 10 years have been researched. In this area, advantages of nanotechnological approaches to provide an effective drug concentration in the disease site are highlighted, together with microneedles as innovative candidates for drug delivery systems in psoriasis and other inflammatory chronic skin diseases.
Collapse
Affiliation(s)
- Robert Gironés Petit
- Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy, University of Barcelona, 08028 Barcelona, Spain; (R.G.P.); (A.C.); (A.O.); (M.E.); (J.P.); (M.M.); (M.L.G.)
| | - Amanda Cano
- Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy, University of Barcelona, 08028 Barcelona, Spain; (R.G.P.); (A.C.); (A.O.); (M.E.); (J.P.); (M.M.); (M.L.G.)
- Institute of Nanoscience and Nanotechnology, Universitat de Barcelona, 08028 Barcelona, Spain
- Center for Biomedical Research in Neurodegenerative Diseases Network, Carlos III Health Institute, 28031 Madrid, Spain
| | - Alba Ortiz
- Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy, University of Barcelona, 08028 Barcelona, Spain; (R.G.P.); (A.C.); (A.O.); (M.E.); (J.P.); (M.M.); (M.L.G.)
- Institute of Nanoscience and Nanotechnology, Universitat de Barcelona, 08028 Barcelona, Spain
| | - Marta Espina
- Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy, University of Barcelona, 08028 Barcelona, Spain; (R.G.P.); (A.C.); (A.O.); (M.E.); (J.P.); (M.M.); (M.L.G.)
- Institute of Nanoscience and Nanotechnology, Universitat de Barcelona, 08028 Barcelona, Spain
| | - Josefina Prat
- Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy, University of Barcelona, 08028 Barcelona, Spain; (R.G.P.); (A.C.); (A.O.); (M.E.); (J.P.); (M.M.); (M.L.G.)
- Institute of Nanoscience and Nanotechnology, Universitat de Barcelona, 08028 Barcelona, Spain
| | - Montserrat Muñoz
- Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy, University of Barcelona, 08028 Barcelona, Spain; (R.G.P.); (A.C.); (A.O.); (M.E.); (J.P.); (M.M.); (M.L.G.)
- Institute of Nanoscience and Nanotechnology, Universitat de Barcelona, 08028 Barcelona, Spain
| | - Patrícia Severino
- University of Tiradentes (Unit) Av. Murilo Dantas, Aracaju 49010-390, Brazil;
- Institute of Technology and Research (ITP) Av. Murilo Dantas, Aracaju 49010-390, Brazil
| | - Eliana B. Souto
- CEB—Centre of Biological Engineering, Campus de Gualtar, University of Minho, 4710-057 Braga, Portugal
- Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
| | - Maria L. García
- Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy, University of Barcelona, 08028 Barcelona, Spain; (R.G.P.); (A.C.); (A.O.); (M.E.); (J.P.); (M.M.); (M.L.G.)
- Institute of Nanoscience and Nanotechnology, Universitat de Barcelona, 08028 Barcelona, Spain
- Center for Biomedical Research in Neurodegenerative Diseases Network, Carlos III Health Institute, 28031 Madrid, Spain
| | - Montserrat Pujol
- Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy, University of Barcelona, 08028 Barcelona, Spain; (R.G.P.); (A.C.); (A.O.); (M.E.); (J.P.); (M.M.); (M.L.G.)
- Institute of Nanoscience and Nanotechnology, Universitat de Barcelona, 08028 Barcelona, Spain
| | - Elena Sánchez-López
- Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy, University of Barcelona, 08028 Barcelona, Spain; (R.G.P.); (A.C.); (A.O.); (M.E.); (J.P.); (M.M.); (M.L.G.)
- Institute of Nanoscience and Nanotechnology, Universitat de Barcelona, 08028 Barcelona, Spain
- Center for Biomedical Research in Neurodegenerative Diseases Network, Carlos III Health Institute, 28031 Madrid, Spain
| |
Collapse
|
10
|
Recent Advances in Nanomaterials for Dermal and Transdermal Applications. COLLOIDS AND INTERFACES 2021. [DOI: 10.3390/colloids5010018] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
The stratum corneum, the most superficial layer of the skin, protects the body against environmental hazards and presents a highly selective barrier for the passage of drugs and cosmetic products deeper into the skin and across the skin. Nanomaterials can effectively increase the permeation of active molecules across the stratum corneum and enable their penetration into deeper skin layers, often by interacting with the skin and creating the distinct sites with elevated local concentration, acting as reservoirs. The flux of the molecules from these reservoirs can be either limited to the underlying skin layers (for topical drug and cosmeceutical delivery) or extended across all the sublayers of the epidermis to the blood vessels of the dermis (for transdermal delivery). The type of the nanocarrier and the physicochemical nature of the active substance are among the factors that determine the final skin permeation pattern and the stability of the penetrant in the cutaneous environment. The most widely employed types of nanomaterials for dermal and transdermal applications include solid lipid nanoparticles, nanovesicular carriers, microemulsions, nanoemulsions, and polymeric nanoparticles. The recent advances in the area of nanomaterial-assisted dermal and transdermal delivery are highlighted in this review.
Collapse
|
11
|
Abstract
Cosmetics composed of synthetic and/or semi-synthetic polymers, associated or not with natural polymers, exhibit a dashing design, with thermal and chemo-sensitive properties. Cosmetic polymers are also used for the preparation of nanoparticles for the delivery of, e.g., fragrances, with the purpose to modify their release profile and also reducing the risk of evaporation. Besides, other cosmetically active nutrients, dermal permeation enhancers, have also been loaded into nanoparticles to improve their bioactivities on the skin. The use of natural polymers in cosmetic formulations is of particular relevance because of their biocompatible, safe, and eco-friendly character. These formulations are highly attractive and marketable to consumers, and are suitable for a plethora of applications, including make-up, skin, and hair care, and as modifiers and stabilizers. In this review, natural synthetic, semi-synthetic, and synthetic polymers are discussed considering their properties for cosmetic applications. Their uses in conventional and novel formulations are also presented.
Collapse
|
12
|
de Carvalho FMDA, Schneider JK, de Jesus CVF, de Andrade LN, Amaral RG, David JM, Krause LC, Severino P, Soares CMF, Caramão Bastos E, Padilha FF, Gomes SVF, Capasso R, Santini A, Souto EB, de Albuquerque-Júnior RLC. Brazilian Red Propolis: Extracts Production, Physicochemical Characterization, and Cytotoxicity Profile for Antitumor Activity. Biomolecules 2020; 10:biom10050726. [PMID: 32384801 PMCID: PMC7277404 DOI: 10.3390/biom10050726] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2020] [Revised: 04/30/2020] [Accepted: 05/01/2020] [Indexed: 12/11/2022] Open
Abstract
Brazilian red propolis has been proposed as a new source of compounds with cytotoxic activity. Red propolis is a resinous material of vegetal origin, synthesized from the bees of the Appis mellifera family, with recognized biological properties. To obtain actives of low polarity and high cytotoxic profile from red propolis, in this work, we proposed a new solvent accelerated extraction method. A complete 23 factorial design was carried out to evaluate the influence of the independent variables or factors (e.g., temperature, number of cycles, and extraction time) on the dependent variable or response (i.e., yield of production). The extracts were analyzed by gas chromatography coupled with mass spectrometry for the identification of chemical compounds. Gas chromatography analysis revealed the presence of hydrocarbons, alcohols, ketones, ethers, and terpenes, such as lupeol, lupenone, and lupeol acetate, in most of the obtained extracts. To evaluate the cytotoxicity profile of the obtained bioactives, the 3-(4,5-dimethyl-2-thiazole)-2,5-diphenyl-2-H-tetrazolium bromide colorimetric assay was performed in different tumor cell lines (HCT116 and PC3). The results show that the extract obtained from 70 °C and one cycle of extraction of 10 min exhibited the highest cytotoxic activity against the tested cell lines. The highest yield, however, did not indicate the highest cytotoxic activity, but the optimal extraction conditions were indeed dependent on the temperature (i.e., 70 °C).
Collapse
Affiliation(s)
- Felipe Mendes de Andrade de Carvalho
- Tiradentes University (UNIT), Av. Murilo Dantas, 300, Aracaju 49010-390, Brazil; (F.M.d.A.d.C.); (J.K.S.); (C.V.F.d.J.); (L.C.K.); (P.S.); (C.M.F.S.); (E.C.B.); (F.F.P.); (S.V.F.G.)
- Institute of Technology and Research (ITP), Av. Murilo Dantas, 300, Aracaju 49032-490, Brazil
| | - Jaderson Kleveston Schneider
- Tiradentes University (UNIT), Av. Murilo Dantas, 300, Aracaju 49010-390, Brazil; (F.M.d.A.d.C.); (J.K.S.); (C.V.F.d.J.); (L.C.K.); (P.S.); (C.M.F.S.); (E.C.B.); (F.F.P.); (S.V.F.G.)
- Institute of Technology and Research (ITP), Av. Murilo Dantas, 300, Aracaju 49032-490, Brazil
| | - Carla Viviane Freitas de Jesus
- Tiradentes University (UNIT), Av. Murilo Dantas, 300, Aracaju 49010-390, Brazil; (F.M.d.A.d.C.); (J.K.S.); (C.V.F.d.J.); (L.C.K.); (P.S.); (C.M.F.S.); (E.C.B.); (F.F.P.); (S.V.F.G.)
- Institute of Technology and Research (ITP), Av. Murilo Dantas, 300, Aracaju 49032-490, Brazil
| | - Luciana Nalone de Andrade
- Federal University of Sergipe (UFS), Avenida Marechal Rondon, São Cristovão 49100-000, Brazil; (L.N.d.A.); (R.G.A.)
| | - Ricardo Guimarães Amaral
- Federal University of Sergipe (UFS), Avenida Marechal Rondon, São Cristovão 49100-000, Brazil; (L.N.d.A.); (R.G.A.)
| | | | - Laíza Canielas Krause
- Tiradentes University (UNIT), Av. Murilo Dantas, 300, Aracaju 49010-390, Brazil; (F.M.d.A.d.C.); (J.K.S.); (C.V.F.d.J.); (L.C.K.); (P.S.); (C.M.F.S.); (E.C.B.); (F.F.P.); (S.V.F.G.)
- Institute of Technology and Research (ITP), Av. Murilo Dantas, 300, Aracaju 49032-490, Brazil
| | - Patrícia Severino
- Tiradentes University (UNIT), Av. Murilo Dantas, 300, Aracaju 49010-390, Brazil; (F.M.d.A.d.C.); (J.K.S.); (C.V.F.d.J.); (L.C.K.); (P.S.); (C.M.F.S.); (E.C.B.); (F.F.P.); (S.V.F.G.)
- Institute of Technology and Research (ITP), Av. Murilo Dantas, 300, Aracaju 49032-490, Brazil
- Tiradentes Institute, 150 Mt Vernon St, Dorchester, MA 02125, USA
| | - Cleide Mara Faria Soares
- Tiradentes University (UNIT), Av. Murilo Dantas, 300, Aracaju 49010-390, Brazil; (F.M.d.A.d.C.); (J.K.S.); (C.V.F.d.J.); (L.C.K.); (P.S.); (C.M.F.S.); (E.C.B.); (F.F.P.); (S.V.F.G.)
- Institute of Technology and Research (ITP), Av. Murilo Dantas, 300, Aracaju 49032-490, Brazil
| | - Elina Caramão Bastos
- Tiradentes University (UNIT), Av. Murilo Dantas, 300, Aracaju 49010-390, Brazil; (F.M.d.A.d.C.); (J.K.S.); (C.V.F.d.J.); (L.C.K.); (P.S.); (C.M.F.S.); (E.C.B.); (F.F.P.); (S.V.F.G.)
- Institute of Technology and Research (ITP), Av. Murilo Dantas, 300, Aracaju 49032-490, Brazil
| | - Francine Ferreira Padilha
- Tiradentes University (UNIT), Av. Murilo Dantas, 300, Aracaju 49010-390, Brazil; (F.M.d.A.d.C.); (J.K.S.); (C.V.F.d.J.); (L.C.K.); (P.S.); (C.M.F.S.); (E.C.B.); (F.F.P.); (S.V.F.G.)
- Institute of Technology and Research (ITP), Av. Murilo Dantas, 300, Aracaju 49032-490, Brazil
| | - Silvana Vieira Flores Gomes
- Tiradentes University (UNIT), Av. Murilo Dantas, 300, Aracaju 49010-390, Brazil; (F.M.d.A.d.C.); (J.K.S.); (C.V.F.d.J.); (L.C.K.); (P.S.); (C.M.F.S.); (E.C.B.); (F.F.P.); (S.V.F.G.)
- Institute of Technology and Research (ITP), Av. Murilo Dantas, 300, Aracaju 49032-490, Brazil
| | - Raffaele Capasso
- Department of Agricultural Sciences, University of Napoli Federico II, Via Università 100, 80055 Portici, Italy;
| | - Antonello Santini
- Department of Pharmacy, University of Napoli Federico II, Via D. Montesano 49, 80131 Napoli, Italy;
| | - Eliana Barbosa Souto
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
- CEB-Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal
- Correspondence: (E.B.S.); (R.L.C.d.A.-J.)
| | - Ricardo Luiz Cavalcanti de Albuquerque-Júnior
- Tiradentes University (UNIT), Av. Murilo Dantas, 300, Aracaju 49010-390, Brazil; (F.M.d.A.d.C.); (J.K.S.); (C.V.F.d.J.); (L.C.K.); (P.S.); (C.M.F.S.); (E.C.B.); (F.F.P.); (S.V.F.G.)
- Institute of Technology and Research (ITP), Av. Murilo Dantas, 300, Aracaju 49032-490, Brazil
- Correspondence: (E.B.S.); (R.L.C.d.A.-J.)
| |
Collapse
|
13
|
Andreani T, Dias-Ferreira J, Fangueiro JF, Souza ALR, Kiill CP, Gremião MPD, García ML, Silva AM, Souto EB. Formulating octyl methoxycinnamate in hybrid lipid-silica nanoparticles: An innovative approach for UV skin protection. Heliyon 2020; 6:e03831. [PMID: 32395645 PMCID: PMC7205751 DOI: 10.1016/j.heliyon.2020.e03831] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2018] [Revised: 01/24/2020] [Accepted: 04/20/2020] [Indexed: 12/27/2022] Open
Abstract
Sunscreens have been employed on daily skin care for centuries. Their role in protecting the skin from sun damage, avoiding accelerated photoaging and even limiting the risk of development of skin cancer is unquestionable. Although several chemical and physical filters are approved as sunscreens for human use, their safety profile is dependent on their concentration in the formulation which governs their acceptance by the regulatory agencies. A strategic delivery of such molecules should provide a UV protection and limit the skin penetration. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) may offer an alternative approach to achieve a synergistic effect on the UV protection when loaded with sunscreens as particles themselves also have a UV light scattering effect. Besides, the lipid character of SLN and NLC improves the encapsulation of lipophilic compounds, with enhanced loading capacity. Silica nanoparticles have also been employed in sunscreen formulations. Due to the formed sol-gel complexes, which covalently entrap sunscreen molecules, a controlled release is also achieved. In the present work, we have developed a new sunscreen formulation composed of hybrid SLN-Silica particles loaded with octyl methoxycinnamate (Parsol®MCX), and their further incorporation into a hydrogel for skin administration. Hybrid SLN-silica particles of 210.0 ± 3.341 nm of mean size, polydispersity below 0.3, zeta potential of ca. |7| mV, loading capacity of 19.9% and encapsulation efficiency of 98.3% have been produced. Despite the slight negative surface charge, the developed hybrid nanoparticles remained physicochemically stable over the study period. Turbiscan transmission profiles confirmed the colloidal stability of the formulations under stress conditions. The texture profile analysis of Parsol-SLN and Parsol-SLN-Si revealed semi-solid properties (e.g. adhesiveness, hardness, cohesiveness, springiness, gumminess, chewiness, resilience) suitable for topical application, together with the bioadhesiveness in the skin of pig ears. The non-irritation profile of the hybrid nanoparticles before and after dispersion into Carbopol hydrogels was confirmed by HET-CAM test.
Collapse
Affiliation(s)
- T Andreani
- Department of Biology and Environment, University of Tras-os-Montes e Alto Douro, UTAD, Quinta de Prados, P-5001-801 Vila Real, Portugal.,Centre for Research and Technology of Agro-Environmental and Biological Sciences (CITAB-UTAD), Quinta de Prados, 5001-801 Vila Real, Portugal
| | - J Dias-Ferreira
- Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
| | - J F Fangueiro
- Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
| | - A L R Souza
- School of Pharmaceutical Sciences, UNESP - Universidade Estadual Paulista, Rodovia Araraquara-Jau Km 1, Araraquara, SP 14801-902, Brazil
| | - C P Kiill
- School of Pharmaceutical Sciences, UNESP - Universidade Estadual Paulista, Rodovia Araraquara-Jau Km 1, Araraquara, SP 14801-902, Brazil
| | - M P D Gremião
- School of Pharmaceutical Sciences, UNESP - Universidade Estadual Paulista, Rodovia Araraquara-Jau Km 1, Araraquara, SP 14801-902, Brazil
| | - M L García
- Department of Physical Chemistry, Faculty of Pharmacy, University of Barcelona, Av. Joan XXIII s/n, 08028 Barcelona, Spain.,Institute of Nanoscience and Nanotechnology, University of Barcelona, Av. Joan XXIII s/n, 08028 Barcelona, Spain
| | - A M Silva
- Department of Biology and Environment, University of Tras-os-Montes e Alto Douro, UTAD, Quinta de Prados, P-5001-801 Vila Real, Portugal.,Centre for Research and Technology of Agro-Environmental and Biological Sciences (CITAB-UTAD), Quinta de Prados, 5001-801 Vila Real, Portugal
| | - E B Souto
- Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal.,CEB - Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal
| |
Collapse
|
14
|
Nanopharmaceutics: Part II-Production Scales and Clinically Compliant Production Methods. NANOMATERIALS 2020; 10:nano10030455. [PMID: 32143286 PMCID: PMC7153617 DOI: 10.3390/nano10030455] [Citation(s) in RCA: 40] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/21/2020] [Revised: 02/22/2020] [Accepted: 03/03/2020] [Indexed: 01/13/2023]
Abstract
Due the implementation of nanotechnologies in the pharmaceutical industry over the last few decades, new type of cutting-edge formulations-nanopharmaceutics-have been proposed. These comprise pharmaceutical products at the nanoscale, developed from different types of materials with the purpose to, e.g., overcome solubility problems of poorly water-soluble drugs, the pharmacokinetic and pharmacodynamic profiles of known drugs but also of new biomolecules, to modify the release profile of loaded compounds, or to decrease the risk of toxicity by providing site-specific delivery reducing the systemic distribution and thus adverse side effects. To succeed with the development of a nanopharmaceutical formulation, it is first necessary to analyze the type of drug which is to be encapsulated, select the type matrix to load it (e.g., polymers, lipids, polysaccharides, proteins, metals), followed by the production procedure. Together these elements have to be compatible with the administration route. To be launched onto the market, the selected production method has to be scaled-up, and quality assurance implemented for the product to reach clinical trials, during which in vivo performance is evaluated. Regulatory issues concerning nanopharmaceutics still require expertise for harmonizing legislation and a clear understanding of clinically compliant production methods. The first part of this study addressing "Nanopharmaceutics: Part I-Clinical trials legislation and Good Manufacturing Practices (GMP) of nanotherapeutics in the EU" has been published in Pharmaceutics. This second part complements the study with the discussion about the production scales and clinically compliant production methods of nanopharmaceutics.
Collapse
|
15
|
Nanomaterials for Skin Delivery of Cosmeceuticals and Pharmaceuticals. APPLIED SCIENCES-BASEL 2020. [DOI: 10.3390/app10051594] [Citation(s) in RCA: 40] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Skin aging is described as dermatologic changes either naturally occurring over the course of years or as the result of the exposure to environmental factors (e.g., chemical products, pollution, infrared and ultraviolet radiations). The production of collagen and elastin, the main structural proteins responsible for skin strength and elasticity, is reduced during aging, while their role in skin rejuvenation can trigger a wrinkle reversing effect. Elasticity loss, wrinkles, dry skin, and thinning are some of the signs that can be associated with skin aging. To overcome skin aging, many strategies using natural and synthetic ingredients are being developed aiming to reduce the signs of aging and/or to treat age-related skin problems (e.g., spots, hyper- or hypopigmentation). Among the different approaches in tissue regeneration, the use of nanomaterials loaded with cosmeceuticals (e.g., phytochemicals, vitamins, hyaluronic acid, and growth factors) has become an interesting alternative. Based on their bioactivities and using different nanoformulations as efficient delivery systems, several cosmeceutical and pharmaceutical products are now available on the market aiming to mitigate the signs of aged skin. This manuscript discusses the state of the art of nanomaterials commonly used for topical administration of active ingredients formulated in nanopharmaceuticals and nanocosmeceuticals for skin anti-aging.
Collapse
|
16
|
Souto EB, Baldim I, Oliveira WP, Rao R, Yadav N, Gama FM, Mahant S. SLN and NLC for topical, dermal, and transdermal drug delivery. Expert Opin Drug Deliv 2020; 17:357-377. [PMID: 32064958 DOI: 10.1080/17425247.2020.1727883] [Citation(s) in RCA: 147] [Impact Index Per Article: 36.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Introduction: From a biopharmaceutical standpoint, the skin is recognized as an interesting route for drug delivery. In general, small molecules are able to penetrate the stratum corneum, the outermost layer of the skin. In contrast, the delivery of larger molecules, such as peptides and proteins, remains a challenge. Nanoparticles have been exploited not only to enhance skin penetration of drugs but also to expand the range of molecules to be clinically used.Areas covered: This review focus on Solid lipid nanoparticles (SLN) and Nanostructured lipid carriers (NLC) for skin administration. We discuss the selection criteria for lipids, surfactants, and surface modifiers commonly in use in SLN/NLC, their production techniques, and the range of drugs loaded in these lipid nanoparticles for the treatment of skin disorders.Expert opinion: Depending on the lipid and surfactant composition, different nanoparticle morphologies can be generated. Both SLN and NLC are composed of lipids that resemble those of the skin and sebum, which contribute to their enhanced biocompatibility, with limited toxicological risk. SLN and NLC can be loaded with very chemically different drugs, may provide a tunable release profile, can be produced in a sterilized environment, and be scaled-up without the need for organic solvents.
Collapse
Affiliation(s)
- Eliana B Souto
- Faculty of Pharmacy, University of Coimbra (FFUC), Coimbra, Portugal.,CEB - Centre of Biological Engineering, University of Minho, Braga, Portugal
| | - Iara Baldim
- CEB - Centre of Biological Engineering, University of Minho, Braga, Portugal.,Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, SP, Brazil
| | - Wanderley P Oliveira
- Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, SP, Brazil
| | - Rekha Rao
- Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, India
| | - Nitesh Yadav
- Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, India
| | - Francisco M Gama
- CEB - Centre of Biological Engineering, University of Minho, Braga, Portugal
| | - Sheefali Mahant
- Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, India
| |
Collapse
|